Emerging at the UK, retatrutide, a new compound , is sparking considerable buzz within the scientific community regarding its potential for weight management . This dual GIP and GLP-1 agent agonist looks to provide a significant advantage over current therapies, showing encouraging results in preliminary clinical trials . Researchers think its u… Read More